Cargando…

Kawasaki Disease and Hyponatremia

Detalles Bibliográficos
Autor principal:	Kil, Hong Ryang
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2010
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978290/ https://www.ncbi.nlm.nih.gov/pubmed/21088751 http://dx.doi.org/10.4070/kcj.2010.40.10.489

Ejemplares similares

Hyponatremia and Syndrome of Inappropriate Antidiuretic Hormone Secretion in Kawasaki Disease
por: Lim, Goh-Woon, et al.
Publicado: (2010)

Association between Adipokines and Coronary Artery Lesions in Children with Kawasaki Disease
por: Kim, Hyun Jung, et al.
Publicado: (2014)

Clinical outcome of patients with refractory Kawasaki disease based on treatment modalities
por: Kim, Hyun Jung, et al.
Publicado: (2016)

The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease
por: Kim, Hyun Jung, et al.
Publicado: (2017)

The outcome of short-term low-dose aspirin treatment in Kawasaki disease based on inflammatory markers
por: Yoo, Jae Won, et al.
Publicado: (2017)

Changes of clinical characteristics and outcomes in patients with Kawasaki disease over the past 7 years in a single center study
por: Kang, Hye Jin, et al.
Publicado: (2013)

Cardiovascular risk factors of early atherosclerosis in school-aged children after Kawasaki disease
por: Cho, Hyun Jeong, et al.
Publicado: (2014)

Changes in clinical and laboratory features of Kawasaki disease noted over time in Daejeon, Korea
por: Kil, Hong-Ryang, et al.
Publicado: (2017)

Elevated Plasma Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor-1 Levels in Refractory Kawasaki Disease
por: Lee, Yu-Ran, et al.
Publicado: (2022)

Factors Predicting Resistance to Intravenous Immunoglobulin and Coronary Complications in Kawasaki Disease: IVIG Resistance in Kawasaki Disease
por: Han, Ji Whan
Publicado: (2017)

Kawasaki Disease in Adulthood
por: Hammad, Basma, et al.
Publicado: (2021)

Consortium-Based Genetic Studies of Kawasaki Disease in Korea: Korean Kawasaki Disease Genetics Consortium
por: Lee, Jong-Keuk, et al.
Publicado: (2015)

Kawasaki Disease, MIS-C and COVID-19
por: Huang, Ying-Hsien, et al.
Publicado: (2023)

Clinical implications in laboratory parameter values in acute Kawasaki disease for early diagnosis and proper treatment
por: Seo, Yu-Mi, et al.
Publicado: (2018)

Hyponatremia in the critically ill: Time for a change
por: Lindner, Gregor
Publicado: (2014)

Does any specific infection cause Kawasaki disease?
por: Lee, Dong Seok
Publicado: (2019)

Recent research trends in Kawasaki disease-related infection
por: Woo, Hyang-Ok
Publicado: (2022)

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
por: Han, Ji Whan
Publicado: (2017)

Another compelling evidence suggesting infectious diseases as the cause of Kawasaki disease?
por: Lai, Chou-Cheng
Publicado: (2020)

Risk Factors Related to Coronary Artery Outcome in Kawasaki Disease
por: Kim, Soo-Jin
Publicado: (2018)

Infliximab, Is It Really a New Horizon for the Treatment of Kawasaki Disease?
por: Eun, Lucy Youngmin
Publicado: (2019)

Predictive risk factors of coronary artery aneurysms in Kawasaki disease
por: Woo, Hyang-Ok
Publicado: (2019)

Circular RNA as a Possible Novel Biomarker for Kawasaki Disease
por: Yoon, Kyung Lim
Publicado: (2019)

IgA Levels Are Associated with Coronary Artery Lesions in Kawasaki Disease
por: Kim, Jae-Jung, et al.
Publicado: (2021)

Understanding Kawasaki Disease on the Ground of Pediatric Growth and Lymphoid Tissue Maturation
por: Oh, Jin-Hee
Publicado: (2017)

Can iron be a risk factor for coronary lesions in Kawasaki disease?
por: Yoon, Kyung Lim
Publicado: (2019)

Can the accurate epidemiological study help to search the etiology of Kawasaki disease?
por: Han, Ji Whan
Publicado: (2020)

An Unintended Consequence of Pandemic Control Measures: Fewer Cases of Kawasaki Disease
por: Shulman, Stanford T., et al.
Publicado: (2021)

Characteristics of z score systems for diagnosing coronary abnormalities in Kawasaki disease
por: Yoo, Gyeong-Hee
Publicado: (2022)

Kawasaki Disease and Infections: A Myth or a Reality?
por: Gupta, Anju
Publicado: (2022)

Identification of rare coding variants associated with Kawasaki disease by whole exome sequencing
por: Kim, Jae-Jung, et al.
Publicado: (2021)

Diagnostic Applications for Clinical and Imaging Data in Kawasaki Disease with Lymphadenopathy-First-Presentation
por: Son, Jae Sung
Publicado: (2018)

Long-Term Outcome of Kawasaki Disease Complicated by a Large Coronary Aneurysm
por: Jung, Jo Won
Publicado: (2017)

Application of established pathophysiologic processes brings greater clarity to diagnosis and treatment of hyponatremia
por: Maesaka, John K, et al.
Publicado: (2017)

A novel role of copeptin as a biomarker for the prediction of treatment response in hyponatremia
por: Suh, Sang Heon, et al.
Publicado: (2021)

Could Immunoglobulin Level Be a Prognostic Factor for Coronary Artery Lesions in Kawasaki Diseases?
por: Han, Mi Young
Publicado: (2021)

Assessment of the Clinical Heterogeneity of Kawasaki Disease Using Genetic Variants of BLK and FCGR2A
por: Sim, Bo Kyung, et al.
Publicado: (2018)

Hyponatremia in Patients with Hematologic Diseases
por: Koumpis, Epameinondas, et al.
Publicado: (2020)

Kawasaki Disease During COVID-19 Pandemic in Korea – Data Were Added but Are Needed More
por: Jo, Dae Sun
Publicado: (2022)

Is multisystem inflammatory syndrome related with coronavirus disease 2019, Kawasaki disease, and angiotensin-converting enzyme 2 in children?
por: Eun, Lucy Youngmin
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ho3mgc3t2t1nit7aodd73386hn